• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群——抗病毒治疗的有前途靶点?

Intestinal Microbiota-A Promising Target for Antiviral Therapy?

机构信息

Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, China.

Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

出版信息

Front Immunol. 2021 May 12;12:676232. doi: 10.3389/fimmu.2021.676232. eCollection 2021.

DOI:10.3389/fimmu.2021.676232
PMID:34054866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8149780/
Abstract

The intestinal microbiota is thought to be an important biological barrier against enteric pathogens. Its depletion, however, also has curative effects against some viral infections, suggesting that different components of the intestinal microbiota can play both promoting and inhibitory roles depending on the type of viral infection. The two primary mechanisms by which the microbiota facilitates or inhibits viral invasion involve participation in the innate and adaptive immune responses and direct or indirect interaction with the virus, during which the abundance and composition of the intestinal microbiota might be changed by the virus. Oral administration of probiotics, faecal microbiota transplantation (FMT), and antibiotics are major therapeutic strategies for regulating intestinal microbiota balance. However, these three methods have shown limited curative effects in clinical trials. Therefore, the intestinal microbiota might represent a new and promising supplementary antiviral therapeutic target, and more efficient and safer methods for regulating the microbiota require deeper investigation. This review summarizes the latest research on the relationship among the intestinal microbiota, anti-viral immunity and viruses and the most commonly used methods for regulating the intestinal microbiota with the goal of providing new insight into the antiviral effects of the gut microbiota.

摘要

肠道微生物群被认为是对抗肠道病原体的重要生物屏障。然而,它的耗竭也对一些病毒感染有治疗效果,这表明肠道微生物群的不同成分可以根据病毒感染的类型发挥促进和抑制作用。微生物群促进或抑制病毒入侵的两种主要机制涉及参与先天和适应性免疫反应以及与病毒的直接或间接相互作用,在此期间,病毒可能会改变肠道微生物群的丰度和组成。益生菌的口服给药、粪便微生物群移植(FMT)和抗生素是调节肠道微生物群平衡的主要治疗策略。然而,这三种方法在临床试验中显示出有限的疗效。因此,肠道微生物群可能代表一个新的、有前途的辅助抗病毒治疗靶点,需要更深入地研究更有效和更安全的调节微生物群的方法。本综述总结了肠道微生物群、抗病毒免疫和病毒之间关系的最新研究,以及最常用于调节肠道微生物群的方法,以期为肠道微生物群的抗病毒作用提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c15/8149780/47aa9bbf239c/fimmu-12-676232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c15/8149780/a831e50c4900/fimmu-12-676232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c15/8149780/47aa9bbf239c/fimmu-12-676232-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c15/8149780/a831e50c4900/fimmu-12-676232-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c15/8149780/47aa9bbf239c/fimmu-12-676232-g002.jpg

相似文献

1
Intestinal Microbiota-A Promising Target for Antiviral Therapy?肠道微生物群——抗病毒治疗的有前途靶点?
Front Immunol. 2021 May 12;12:676232. doi: 10.3389/fimmu.2021.676232. eCollection 2021.
2
The microbiota-mediated dietary and nutritional interventions for COVID-19.肠道菌群介导的 COVID-19 膳食和营养干预措施。
Clin Immunol. 2021 May;226:108725. doi: 10.1016/j.clim.2021.108725. Epub 2021 Apr 9.
3
Probiotics in Medicine: A Long Debate.医学中的益生菌:一场旷日持久的争论。
Front Immunol. 2020 Sep 25;11:2192. doi: 10.3389/fimmu.2020.02192. eCollection 2020.
4
Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.益生菌、光生物调节与疾病管理:争议与挑战。
Int J Mol Sci. 2021 May 6;22(9):4942. doi: 10.3390/ijms22094942.
5
Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.肠道微生物群在预防和治疗脓毒症中的治疗潜力。
Front Immunol. 2018 Sep 10;9:2042. doi: 10.3389/fimmu.2018.02042. eCollection 2018.
6
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.肠道微生物群在炎症性肠病发病机制中的作用:治疗的潜力。
Pharmacol Ther. 2015 May;149:191-212. doi: 10.1016/j.pharmthera.2014.12.006. Epub 2015 Jan 3.
7
Commensal gut microbiota can modulate adaptive immune responses in chickens vaccinated with whole inactivated avian influenza virus subtype H9N2.共生肠道微生物群可以调节接种全灭活禽流感病毒亚型 H9N2 疫苗的鸡的适应性免疫反应。
Vaccine. 2019 Oct 16;37(44):6640-6647. doi: 10.1016/j.vaccine.2019.09.046. Epub 2019 Sep 18.
8
Early-Life Intervention Using Fecal Microbiota Combined with Probiotics Promotes Gut Microbiota Maturation, Regulates Immune System Development, and Alleviates Weaning Stress in Piglets.早期生活干预使用粪便微生物群联合益生菌可促进肠道微生物群成熟、调节免疫系统发育并减轻仔猪断奶应激。
Int J Mol Sci. 2020 Jan 13;21(2):503. doi: 10.3390/ijms21020503.
9
[Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].[肠易激综合征中肠道微生物群的治疗性调节。从益生菌到粪便微生物群疗法]
MMW Fortschr Med. 2017 Dec;159(Suppl 7):1-5. doi: 10.1007/s15006-017-0338-3. Epub 2017 Dec 4.
10
Future prospect of faecal microbiota transplantation as a potential therapy in asthma.粪便微生物群移植作为哮喘潜在治疗方法的未来前景。
Allergol Immunopathol (Madr). 2018 May-Jun;46(3):307-309. doi: 10.1016/j.aller.2017.04.008. Epub 2017 Aug 10.

引用本文的文献

1
Characterizing Gene-Level Adaptations in the Gut Microbiome During Viral Infections: The Role of a Fucoidan-Rich Extract.表征病毒感染期间肠道微生物群中的基因水平适应性:富含岩藻依聚糖提取物的作用。
Genes (Basel). 2025 Jun 26;16(7):740. doi: 10.3390/genes16070740.
2
Virus-host interaction mechanisms in interferon therapy for hepatitis B virus infection: recent advances.乙型肝炎病毒感染干扰素治疗中的病毒-宿主相互作用机制:最新进展
Front Immunol. 2025 Jun 27;16:1603544. doi: 10.3389/fimmu.2025.1603544. eCollection 2025.
3
Gut Microbiota in a Viral Model of Multiple Sclerosis: Modulation and Pitfalls by Oral Antibiotic Treatment.

本文引用的文献

1
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.肠道微生物群落组成反映了 COVID-19 患者的疾病严重程度和功能失调的免疫反应。
Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.
2
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study).肠道微生物群相关的黄连素和益生菌对 2 型糖尿病的影响(PREMOTE 研究)。
Nat Commun. 2020 Oct 6;11(1):5015. doi: 10.1038/s41467-020-18414-8.
3
Evaluating Organism-Wide Changes in the Metabolome and Microbiome following a Single Dose of Antibiotic.
多发性硬化症病毒模型中的肠道微生物群:口服抗生素治疗的调节作用与陷阱
Cells. 2025 Jun 9;14(12):871. doi: 10.3390/cells14120871.
4
Recent insights and advances in gut microbiota's influence on host antiviral immunity.肠道微生物群对宿主抗病毒免疫影响的最新见解与进展
Front Microbiol. 2025 Feb 27;16:1536778. doi: 10.3389/fmicb.2025.1536778. eCollection 2025.
5
Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies.乙型肝炎病毒再激活的免疫学机制概述:对疾病进展和管理策略的影响。
World J Gastroenterol. 2024 Mar 14;30(10):1295-1312. doi: 10.3748/wjg.v30.i10.1295.
6
Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases.微生物组动态:抗击传染病的范式转变。
J Pers Med. 2024 Feb 18;14(2):217. doi: 10.3390/jpm14020217.
7
The impact of probiotics and vitamin C on the prevention of upper respiratory tract symptoms in two preschool children cohorts.益生菌和维生素C对两个学龄前儿童队列预防上呼吸道症状的影响。
Nutr Res Pract. 2024 Feb;18(1):98-109. doi: 10.4162/nrp.2024.18.1.98. Epub 2023 Dec 1.
8
Mini-review: microbiota have potential to prevent PEDV infection by improved intestinal barrier.综述:肠道微生物群有潜力通过改善肠道屏障来预防猪流行性腹泻病毒感染。
Front Immunol. 2023 Jul 12;14:1230937. doi: 10.3389/fimmu.2023.1230937. eCollection 2023.
9
Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.头孢菌素诱导的肠道菌群失调加重肺炎链球菌感染小鼠的肺内皮屏障破坏。
Front Cell Infect Microbiol. 2022 Aug 24;12:997368. doi: 10.3389/fcimb.2022.997368. eCollection 2022.
10
The role of intestinal microbiota and its metabolites in intestinal and extraintestinal organ injury induced by intestinal ischemia reperfusion injury.肠道微生物群及其代谢物在肠道缺血再灌注损伤引起的肠道和肠道外器官损伤中的作用。
Int J Biol Sci. 2022 Jun 13;18(10):3981-3992. doi: 10.7150/ijbs.71491. eCollection 2022.
评估单次使用抗生素后机体代谢组和微生物组的整体变化。
mSystems. 2020 Oct 6;5(5):e00340-20. doi: 10.1128/mSystems.00340-20.
4
Ethanol extract of Centella asiatica alleviated dextran sulfate sodium-induced colitis: Restoration on mucosa barrier and gut microbiota homeostasis.积雪草乙醇提取物缓解葡聚糖硫酸钠诱导的结肠炎:恢复黏膜屏障和肠道微生物群稳态。
J Ethnopharmacol. 2021 Mar 1;267:113445. doi: 10.1016/j.jep.2020.113445. Epub 2020 Oct 3.
5
α-Defensins Promote Colonization on Mucosal Reservoir to Prevent Antibiotic-Induced Dysbiosis.α-防御素促进在黏膜储存部位的定殖以预防抗生素诱导的生态失调。
Front Immunol. 2020 Sep 9;11:2065. doi: 10.3389/fimmu.2020.02065. eCollection 2020.
6
Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiota.参衍康福片通过减轻炎症和调节肠道微生物群来缓解糖尿病肾病。
J Nat Med. 2021 Jan;75(1):84-98. doi: 10.1007/s11418-020-01452-3. Epub 2020 Sep 30.
7
Understanding the impact of antibiotic perturbation on the human microbiome.了解抗生素扰动对人类微生物组的影响。
Genome Med. 2020 Sep 28;12(1):82. doi: 10.1186/s13073-020-00782-x.
8
Effects of β-Lactam Antibiotics on Gut Microbiota Colonization and Metabolites in Late Preterm Infants.β-内酰胺类抗生素对晚期早产儿肠道定植菌及代谢产物的影响。
Curr Microbiol. 2020 Dec;77(12):3888-3896. doi: 10.1007/s00284-020-02198-7. Epub 2020 Sep 24.
9
Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.小檗碱通过改变肠道微生物群和减少芳香族氨基酸来缓解 2 型糖尿病症状。
Biomed Pharmacother. 2020 Nov;131:110669. doi: 10.1016/j.biopha.2020.110669. Epub 2020 Sep 13.
10
Xianglian Pill ameliorates antibiotic-associated diarrhea by restoring intestinal microbiota and attenuating mucosal damage.香连丸通过恢复肠道微生物群和减轻黏膜损伤来改善抗生素相关性腹泻。
J Ethnopharmacol. 2021 Jan 10;264:113377. doi: 10.1016/j.jep.2020.113377. Epub 2020 Sep 10.